search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Pharmaceutical & medical A


medical innovation - developed in the UK - is promising to help improve neonatal care and save the lives of more babies born prematurely or in distress.


Europlaz, which has more than 40 years’ experi- ence in manufacturing products for the medical device, diagnostics and life sciences sector, has come up with an integrated ‘sidestream’ CO₂ sampling port that is joined to the side of its existing neonatal flow sensor. This patented addition enables clinicians to follow the correct protocols of using both lung protective volume control and CO₂ monitoring, giving the baby the best chance of survival and limiting the possibility of longer-term conditions, such as cere- bral palsy or lung disease.


It achieves this by combining the sensor for meas- uring flow volume with the optimally placed sampling port for safely extracting gas for tidal flow CO₂ moni- toring, reducing the ‘dead space’ found in existing products and ensuring more accurate readings. Chelmsford-based Europlaz has been developing this innovation for years and believes now is the time for ventilator manufacturers to consider switching to this neonatal flow sensor to save lives, reduce costs to the NHS and avoid expensive litigation. “Momentum is definitely growing, with two global manufacturers adopting our new flow sensors and trials about to begin with a famous London hospital. This will provide the clinical evidence that many of the ventilator manufacturers have been asking for,” explains Frede Jensen product development manager at Europlaz.


“We are dealing with the tiniest of lives, so it is imperative that we give clinical teams the best possible technology to help them do their jobs. This is exactly what this innovation does, with the side sampling port delivering the stable and accurate readings of CO₂ being exhaled that they need to better inform the care of the child, and the level of ventilation support required.” He continues: “Europlaz has been manufacturing neonatal flow sensors for more than ten years and we have sold over one million to date – all without the sampling port. This must change, and we believe that when one hospital or manufacturer commits to it, the rest will follow.


“It just makes too much sense not to. Why not embrace a product that gives you greater clarity, greater control and a greater chance of saving a baby’s life? “There is also a financial element to it as well, with 60 per cent of the NHS’ Resolution’s £9bn liability budget spent in 2018/19 dealing with cases involving maternity care.”


Europlaz is investing heavily in ramping up production for its new neonatal flow sensor, with a brand-new robotic welder arriving shortly. This is the central element to a modern production cell that uses vision controlled micro-robotic wire welding to deliver highly consistent sensor quality, performance and reliability.


Jensen, who has extensive design, development and manufacturing experience in neonatal products, continues: “This latest piece of equipment is very


74


NEONATAL INNOVATION CAN SAVE BABIES LIVES


impressive, with the robot capable of welding a 13-micron precious metal wire (which is 1/3 of the thickness of a human hair) to a surface smaller than a pin head with 5-micron precision.


“Importantly, it gives us the repeatable quality that we know is required and the confidence that our sensors will deliver accurate readings time and time again. We can also increase capacity, with the genuine expectation that we can supply


500,000 sensors every year.”


The innovation being added to the neonatal sensor is just one of the advancements Europlaz is currently working on in this space. It is also a few weeks away from starting exciting trials of its own range of neonatal ventilation monitors at four major UK hospitals.


Europlaz Technologies europlaz.co.uk


January 2025 Instrumentation Monthly


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96